Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

OptiTrain - Optimal Training Women With Breast Cancer

NCT02522260
completednot_applicable

Comparison of the Effect of Exercises on Vasomotor Symptoms in Middle Aged Women

NCT05892094
withdrawnnot_applicable

HEARTS: Heart, Exercise, and Resistance Training Study

NCT00094250

Clinical Trials (3)

Showing 3 of 3 trials
NCT02522260Not Applicable

OptiTrain - Optimal Training Women With Breast Cancer

Completed
NCT05892094Not Applicable

Comparison of the Effect of Exercises on Vasomotor Symptoms in Middle Aged Women

Completed
NCT00094250Not Applicable

HEARTS: Heart, Exercise, and Resistance Training Study

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3